Literature DB >> 30078187

How to influence the mesenchymal stem cells fate? Emerging role of ectoenzymes metabolizing nucleotides.

Katarzyna Roszek1, Magdalena Wujak1.   

Abstract

Extracellular purines, principally adenosine triphosphate and adenosine, are among the oldest evolutionary and widespread chemical messengers. The integrative view of purinergic signaling as a multistage coordinated cascade involves the participation of nucleotides/nucleosides, their receptors, enzymes metabolizing extracellular nucleosides and nucleotides as well as several membrane transporters taking part in the release and/or uptake of these molecules. In view of the emerging data, it is evident and widely accepted that an extensive network of diverse enzymatic activities exists in the extracellular space. The enzymes regulate the availability of nucleotide and adenosine receptor agonists, and consequently, the course of signaling events. The current data indicate that mesenchymal stem cells (MSCs) and cells induced to differentiate exhibit different sensitivity to purinergic ligands as well as a distinct activity and expression profiles of ectonucleotidases than mature cells. In the proposed review, we postulate for a critical role of these enzymatic players which, by orchestrating a fine-tune regulation of nucleotides concentrations, are integrally involved in modulation and diversification of purinergic signals. This specific hallmark of the MSC purinome should be linked with cell-specific biological potential and capacity for tissue regeneration. We anticipate this publication to be a starting point for scientific discussion and novel approach to the in vitro and in vivo regulation of the MSC properties.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  differentiation; ectonucleotidases; ectonucleotides; mesenchymal stem cells (MSCs); purinergic signaling

Mesh:

Substances:

Year:  2018        PMID: 30078187     DOI: 10.1002/jcp.26904

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  4 in total

Review 1.  Mesenchymal Stem Cell-Based Therapy as a New Approach for the Treatment of Systemic Sclerosis.

Authors:  Xiufen Zhuang; Xiao Hu; Shuren Zhang; Xingmin Li; Xiaoying Yuan; Yanhong Wu
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-15       Impact factor: 8.667

2.  In Vivo Sequestration of Innate Small Molecules to Promote Bone Healing.

Authors:  Yuze Zeng; Yu-Ru V Shih; Gurpreet S Baht; Shyni Varghese
Journal:  Adv Mater       Date:  2019-12-12       Impact factor: 30.849

3.  Characterization of the Endometrial MSC Marker Ectonucleoside Triphosphate Diphosphohydrolase-2 (NTPDase2/CD39L1) in Low- and High-Grade Endometrial Carcinomas: Loss of Stromal Expression in the Invasive Phenotypes.

Authors:  Aitor Rodríguez-Martínez; Carla Trapero; August Vidal; Josep Maria Piulats; Inmaculada Gómez de Aranda; Jean Sévigny; Maria Eulàlia Fernández-Montolí; Jordi Ponce; Xavier Matias-Guiu; Mireia Martín-Satué
Journal:  J Pers Med       Date:  2021-04-22

Review 4.  Purinergic Signaling in Endometriosis-Associated Pain.

Authors:  Carla Trapero; Mireia Martín-Satué
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.